MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202517133569 A) filed by Virometix Ag, Schlieren, Switzerland, on Dec. 30, 2025, for 'compositions of pneumococcal antigens.'
Inventor(s) include Stergiou, Lilli; Rodriguez Balboa, Javier; Lamprokostopoulou, Agaristi; Rassek, Oliver; Spoulou, Vana; Mansour, Marc; and Daikopoulou, Vasiliki.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a composition comprising a first pneumococcal antigen comprising a first pneumococcal peptide epitope or a nucleic acid encoding said first pneumococcal antigen, a second pneumococcal antigen comprising a second pneumococcal peptide epitope or a nucleic acid encoding said second pneumococcal antigen, and a third pneumococcal antigen comprising a third pneumococcal peptide epitope or a nucleic acid encoding said third pneumococcal antigen, wherein said first pneumococcal peptide epitope is derived from the non-proline block (NPB) of the Pneumococcal surface protein A (PspA), said second pneumococcal peptide epitope is derived from the proline-rich region (PR) of the Pneumococcal surface protein A (PspA), and said third pneumococcal peptide epitope is derived from the surface-exposed pneumococcal protein PhtE of the histidine triad (Pht) protein family."
The patent application was internationally filed on July 11, 2024, under International application No.PCT/EP2024/069620.
Disclaimer: Curated by HT Syndication.
